CORXEL Pharmaceuticals is a startup based in the United States, 1 tracked investor.
CORXEL Pharmaceuticals is a company headquartered in the United States. Brouky records 1 investor associated with the company.
CORXEL Pharmaceuticals is a biopharmaceutical company developing innovative therapies for cardiometabolic and cardiovascular diseases, with operations in the US and China focused on treating conditions like hypertrophic cardiomyopathy and heart failure.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.